MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1097/qai.0000000000000015

Медицинская библиотека · Journal of acquired immune deficiency syndromes (1999) · 2013

Long-term follow-up of children in the HIVNET 012 perinatal HIV prevention trial: five-year growth and survival.

Owor Maxensia, Mwatha Anthony, Donnell Deborah, Musoke Philippa, Mmiro Francis, Allen Melissa, Jackson J Brooks, Fowler Mary Glenn, Guay Laura A

Клиническое исследование II фазыСтатьяРандомизированное исследованиеПоддержка NIH: внешняя программаПеревод в очереди

Аннотация

OBJECTIVES

To describe 5-year growth, survival, and long-term safety among children exposed to nevirapine or zidovudine in an African perinatal prevention trial, HIVNET 012.

METHODS

All study children who were alive at the age 18 months were eligible for an extended follow-up study. Children whose families consented were enrolled and evaluated every 6 months from 24 to 60 months. At each visit, history, physical examination, and growth measures were taken. From these measurements, Z scores based on World Health Organization (WHO) standards were computed. Serious adverse event data were collected. Data from the initial and extended follow-up cohorts were included in the analysis.

RESULTS

Five hundred twenty-eight study children were alive at the age 18 months, and 491 (426 HIV uninfected and 65 infected) were enrolled into the follow-up study. Both exposed but uninfected children and HIV-infected children were substantially below WHO growth standards for weight and height. Head circumference Z scores for uninfected children were comparable with WHO norms. Five-year survival rates were 93% for uninfected children versus 43% for infected children. Long-term safety and growth outcomes in the 2 study arms were similar.

CONCLUSIONS

Both infected and uninfected children in the 5-year HIVNET 012 follow-up showed poor height and weight growth outcomes, underscoring the need for early nutritional interventions to improve long-term growth of all infants born to HIV-infected women in resource-limited settings. Similarly, the low 5-year survival among HIV-infected children support the importance of early initiation of antiretroviral therapy. Both peripartum nevirapine and zidovudine were safe.

Для цитирования: Owor Maxensia, Mwatha Anthony, Donnell Deborah, Musoke Philippa, Mmiro Francis, Allen Melissa, Jackson J Brooks, Fowler Mary Glenn, Guay Laura A. Long-term follow-up of children in the HIVNET 012 perinatal HIV prevention trial: five-year growth and survival.. Journal of acquired immune deficiency syndromes (1999). 2013. DOI: 10.1097/qai.0000000000000015.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.